Skip to main content
. Author manuscript; available in PMC: 2009 Sep 29.
Published in final edited form as: Arterioscler Thromb Vasc Biol. 2008 May 29;28(9):1614–1620. doi: 10.1161/ATVBAHA.107.158725

Figure 1.

Figure 1

A and B, Morphometric analysis revealed a reduced number of TM+ and SMA+ vessels in the infarcted area of VEGF-B−/− mice, as compared to WT animals (*P<0.05) or to VEGF-B−/− mice, treated with rhVEGF-B167 (#P<0.05 vs no treatment). C–F, Immunostaining showed increased TM+ and SMA+ vessels after delivery of rhVEGF-B167 to WT mice. G and H, Systemic injection of Ad.hVEGF-B167 stimulates the growth of TM+ and SMA+ vessels in the infarct area and border zone of WT mice (*P<0.05). Scale bars: 50 μm.